Coating nanoparticles with cell membranes for targeted drug delivery

被引:110
作者
Gao, Weiwei
Zhang, Liangfang [1 ,2 ]
机构
[1] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
关键词
Biomimetic nanoparticle; cell membrane; drug delivery; nanomedicine; vaccination; POLYMERIC NANOPARTICLES; COATED NANOPARTICLES; ERYTHROCYTE-MEMBRANE; IN-VIVO; BIOMEDICAL APPLICATIONS; BIOMIMETIC DELIVERY; SYNTHETIC VACCINES; ALPHA-HEMOLYSIN; PHASE-I; CANCER;
D O I
10.3109/1061186X.2015.1052074
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Targeted delivery allows drug molecules to preferentially accumulate at the sites of action and thus holds great promise to improve therapeutic index. Among various drug-targeting approaches, nanoparticle-based delivery systems offer some unique strengths and have achieved exciting preclinical and clinical results. Herein, we aim to provide a review on the recent development of cell membrane-coated nanoparticle system, a new class of biomimetic nanoparticles that combine both the functionalities of cellular membranes and the engineering flexibility of synthetic nanomaterials for effective drug delivery and novel therapeutics. This review is particularly focused on novel designs of cell membrane-coated nanoparticles as well as their underlying principles that facilitate the purpose of drug targeting. Three specific areas are highlighted, including: (i) cell membrane coating to prolong nanoparticle circulation, (ii) cell membrane coating to achieve cell-specific targeting and (iii) cell membrane coating for immune system targeting. Overall, cell membrane-coated nanoparticles have emerged as a novel class of targeted nanotherapeutics with strong potentials to improve on drug delivery and therapeutic efficacy for treatment of various diseases.
引用
收藏
页码:619 / 626
页数:8
相关论文
共 80 条
[11]   Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles [J].
Davis, Mark E. ;
Zuckerman, Jonathan E. ;
Choi, Chung Hang J. ;
Seligson, David ;
Tolcher, Anthony ;
Alabi, Christopher A. ;
Yen, Yun ;
Heidel, Jeremy D. ;
Ribas, Antoni .
NATURE, 2010, 464 (7291) :1067-U140
[12]   The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic [J].
Davis, Mark E. .
MOLECULAR PHARMACEUTICS, 2009, 6 (03) :659-668
[13]   Structural elucidation of cell membrane-derived nanoparticles using molecular probes [J].
Fan, Zhiyuan ;
Zhou, Hao ;
Li, Peter Y. ;
Speer, Julie E. ;
Cheng, Hao .
JOURNAL OF MATERIALS CHEMISTRY B, 2014, 2 (46) :8231-8238
[14]   Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery [J].
Fang, Ronnie H. ;
Hu, Che-Ming J. ;
Luk, Brian T. ;
Gao, Weiwei ;
Copp, Jonathan A. ;
Tai, Yiyin ;
O'Connor, Derek E. ;
Zhang, Liangfang .
NANO LETTERS, 2014, 14 (04) :2181-2188
[15]   Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles [J].
Fang, Ronnie H. ;
Hu, Che-Ming J. ;
Chen, Kevin N. H. ;
Luk, Brian T. ;
Carpenter, Cody W. ;
Gao, Weiwei ;
Li, Shulin ;
Zhang, Dong-Er ;
Lu, Weiyue ;
Zhang, Liangfang .
NANOSCALE, 2013, 5 (19) :8884-8888
[16]   Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo [J].
Farokhzad, OC ;
Cheng, JJ ;
Teply, BA ;
Sherifi, I ;
Jon, S ;
Kantoff, PW ;
Richie, JP ;
Langer, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (16) :6315-6320
[17]   Nanomedicine: Developing smarter therapeutic and diagnostic modalities [J].
Farokhzad, Omid C. ;
Langer, Robert .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (14) :1456-1459
[18]  
Farokhzad Omid C, 2012, Clin Adv Hematol Oncol, V10, P543
[19]   Impact of Nanotechnology on Drug Delivery [J].
Farokhzad, Omid C. ;
Langer, Robert .
ACS NANO, 2009, 3 (01) :16-20
[20]   Engineering Red-Blood-Cell-Membrane-Coated Nanoparticles for Broad Biomedical Applications [J].
Gao, Weiwei ;
Zhang, Liangfang .
AICHE JOURNAL, 2015, 61 (03) :738-746